Company and Cycle

Figures converted from Indonesian Rupiah (IDR) at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The setup

PT Japfa Comfeed Indonesia Tbk (IDX: JPFA) is Indonesia's second-largest vertically integrated poultry and animal-feed producer [1], founded in 1971, listed since 1989, and 55.4%-controlled by Singapore-listed parent Japfa Ltd [2]. FY2025 was a record: revenue of $3.64 billion and profit to owners of $240 million — more than four times the 2023 trough — with 1Q2026 profit up 167% year-on-year [3]. Yet the stock trades near $0.12, about 6.4x trailing earnings and below its 2025 year-end close. This report asks whether that gap is opportunity or a correctly-priced peak.

Revenue, profit to owners and EPS: FY2025 audited financial highlights [4]. Market cap and P/E computed at the Rp2,210 close of 3 August 2026 on 11.73 billion issued shares; consensus 12-month target from 13 analysts [5].

What the company actually does

Japfa began in 1971 as a copra-pellet maker, moved into animal feed in 1975, added poultry breeding in 1982, and today runs the full protein chain from feed mill to supermarket shelf [6]. The economics are best understood as one integrated flow: it mills feed, hatches day-old chicks (DOC) under the MB202 brand from Aviagen genetics, raises broilers on commercial farms, processes and brands the meat, and sells the surplus into the open market — with parallel aquaculture (feed and hatcheries) and beef-cattle operations [7].

That integration matters because the segments behave very differently. Commercial farming — live broilers and eggs sold at spot prices — is the largest slice of sales and the most volatile; feed is the smaller, steadier, higher-margin anchor.

Segment net sales, FY2025 financial highlights; the six segments gross to $3.72bn before inter-segment eliminations against consolidated net sales of $3.64bn [8].

Commercial farming is roughly 40% of sales and feed roughly 25%; together with breeding and processing, the poultry chain is close to 90% of the business [9]. Japfa is a price-taker on broiler prices, corn and soybean-meal input costs, and the rupiah — which is exactly why its profits swing.

The cycle is the story

Revenue has risen every single year, from $3.14 billion in 2021 to $3.64 billion in 2025 [10]. Profit did not. Profit to owners collapsed from $142 million in 2021 to $60 million in 2023 — an EPS of just $0.005 — then rebounded to a record $240 million (EPS $0.021) in 2025 [11]. The swing is a margin story, not a demand story: when broiler and DOC prices fall below the cost of corn-based feed, the integrated chain earns very little, and when the supply–demand balance tightens, margins snap back.

Profit for the year attributable to owners of the parent, FY2021–FY2025 audited financial highlights, converted at each year-end FX rate [12].

The recovery has carried into 2026. First-quarter net sales rose 23.6% to $974 million and profit to owners rose to $100 million, up from about $41 million a year earlier — roughly 2.7 times [13]. On the company's own arithmetic, the balance sheet is also the strongest it has been: liabilities of roughly $1.2 billion against equity of roughly $1.2 billion, near 1.0x, after the deleveraging of the past two years [14]. For a reader whose first concern is solvency, that is the important early fact: this is a cyclical, but not a fragile one.

Earnings up, price down

Here is the tension the whole report exists to resolve. Since the 2023 trough, EPS has risen 4.3-fold, but the share price has not kept pace — and it has actually fallen from its 2025 year-end level. The market is paying less for each dollar of Japfa's earnings today (about 6.4x) than it did at the depths of 2023 (14.8x), even though earnings are now at a record.

Year-end share price, EPS, P/E and market cap for 2023–2025 as disclosed in the FY2025 financial highlights, converted at each year-end FX rate; the final row uses the Rp2,210 close of 3 August 2026 and trailing FY2025 EPS [15].

Two readings fit these facts, and separating them is the job of the chapters that follow. One is that Japfa is a founder-controlled cyclical whose earnings, cash generation and balance sheet have all improved, trading at a trough multiple because the market extrapolates the last downturn — the kind of out-of-favour quality a patient buyer looks for. The other is that a ~6x multiple on record, cycle-peak earnings is precisely what an efficient market pays when it expects the next dollar of profit to be lower, not higher. The evidence sits on both sides: the counter to the cheap-stock case is that 2025–26 profits may themselves be the peak, and the 6.4x is discounting a normalisation the analysts' $0.17 target does not.

Ownership and the question this report answers

The reader's first filter — founder skin in the game — is satisfied at the surface: Japfa Ltd holds 55.4% through Japfa Pte Ltd, the public 43.8%, and the company itself 0.8% in treasury [16]. Control rests with the Santoso family through the Singapore parent, which aligns the controller with the minority on price but also raises the related-party and capital-allocation questions a later chapter should test.

That fixes the spine. The central question this report answers is whether JPFA is a mispriced, founder-controlled cyclical compounder — cheap on record earnings because the market distrusts the durability of the Indonesian poultry cycle — or whether its ~6x multiple is the correct discount for an earnings peak about to roll over. Everything that follows — the three-year financials and forward estimates, the segment margins that drive the cycle, insider ownership and pay, the industry's tailwinds, and what the price implies — is in service of answering it.